The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control
Abstract
Background After ingestion of phosphatidylcholine, l-carnitine or betaine, trimethylamine-N-oxide (TMAO) is formed by gut microbiota and liver enzymes. Elevated TMAO plasma levels were associated with increased cardiovascular risk and other diseases. Also betaine and choline itself were recently associated with increased cardiovascular risk.Methods A newly developed LC-HRMS method was applied to measure the plasma concentrations of TMAO, betaine and choline in a cohort of 339 patients undergoing coronary angiography for the evaluation of suspected coronary artery disease.Results Betaine concentrations in males were significantly higher than in females (42.0 vs. 35.9 μmol/L; p < 0.001). Plasma concentrations of TMAO but not of betaine or choline were higher in patients with diabetes compared to euglycemic patients (2.39 vs. 0.980 μmol/L; p = 0.001) as well as in patients with metabolic syndrome as compared to patients without metabolic syndrome (2.37 vs. 1.43 μmol/L; p = 0.002). Plasma concentrations of TMAO or choline increased significantly with decreasing renal function (Spearman's rho: -0.281; p < 0.001). However, plasma levels of TMAO or betaine were associated with neither a history of myocardial infarction nor the angiographically assessed presence of coronary heart disease, nor incident cardiovascular events during 8 years of follow-up. Plasma levels of choline were significantly lower in patients with a history of acute myocardial infarction as compared to those without such history (10.0 vs. 10.8 μmol/L; p = 0.045).Conclusions Plasma levels of TMAO are confounded by impaired kidney function and poor metabolic control but are not associated with the history, presence or incidence of symptoms or events of coronary heart disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mueller et al., (2015) [47] did an 8 years follow-up study trying to relate plasma TMAO, betaine or choline levels with cardiovascular disease (CVD), but the results showed that the levels were confounded by impaired kidney function or poor metabolic control and they were not associated with presence, incidence or events of coronary heart disease.”
From Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target (2018) · cites this paper as [47]
In the citing paper
“Differences in characteristics and disease status of participants across studies might affect TMAO levels14, 27, 28 and therefore partly explain such inconsistency.”
From Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta‐Analysis of Prospective Studies (2017) · cites this paper as [14]
In the citing paper
“Also, another 3 studies did not show a significantly elevated RR when TMAO was analyzed as a continuous variable in model.10, 14, 17”
From Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta‐Analysis of Prospective Studies (2017) · cites this paper as [14]
In the citing paper
“One study14 introduced a newly developed method for the measurement of TMAO, and their IQRs of TMAO were lower than other studies, so that we calculated a RR without data from the study. Results of the analysis showed a similar pooled adjusted RR per 1‐μmol/L increment in TMAO of 1.02 (1.01, 1.04).”
From Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta‐Analysis of Prospective Studies (2017) · cites this paper as [14]
In the citing paper
“In a cohort of 339 patients who underwent coronary angiography, plasma concentrations of TMAO or choline were significantly increased with decreasing renal function, but TMAO concentrations were not associated with incidence or symptoms of coronary heart disease.”
From Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease (2017) · cites this paper as [85]
In the citing paper
“In a cohort of 339 patients who underwent coronary angiography, plasma concentrations of TMAO or choline were significantly increased with decreasing renal function, but TMAO concentrations were not associated with incidence or symptoms of coronary heart disease.”
From Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease (2017) · cites this paper as [85]
In the citing paper
“The study concluded that plasma concentrations of TMAO were confounded by impaired kidney function because it was increased with declining GFR (85).”
From Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease (2017) · cites this paper as [85]
In the citing paper
“The plasma levels of TMAO or betaine were not found to be associated with a history of myocardial infarction, the angiographically-assessed presence of coronary heart disease, or the incident cardiovascular events during 8 years of follow-up.”
From Trimethylamine N-oxide: the good, the bad and the unknown. (2016) · cites this paper as [35]
In the citing paper
“Mueller et al. measured plasma concentrations of TMAO, betaine and choline in a cohort of 339 patients undergoing coronary angiography and noted that plasma concentrations of TMAO were higher in diabetics compared to euglycemic patients [35].”
From Trimethylamine N-oxide: the good, the bad and the unknown. (2016) · cites this paper as [35]
In the citing paper
“TMAO and choline levels increase with decreasing renal function [35].”
From Trimethylamine N-oxide: the good, the bad and the unknown. (2016) · cites this paper as [35]
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 14,094
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s081 · Cited by 5,974
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., & Lionetti, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005963107 · Cited by 5,579
Matuszewski, B. K., Constanzer, M. L., & Chavez-Eng, C. M. (2003) · Analytical Chemistry · doi:10.1021/ac020361s · Cited by 5,426
Heart Disease and Stroke Statistics—2014 Update
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Blaha, M. J., Dai, S., Ford, E. S., Fox, C. S., Franco, S., et al. (2013) · Circulation · doi:10.1161/01.cir.0000441139.02102.80 · Cited by 5,264
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3145 · Cited by 4,386
(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.1 · Cited by 4,326
Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease
Kris-Etherton, P. M., Harris, W. S., & Appel, L. J. (2002) · Circulation · doi:10.1161/01.cir.0000038493.65177.94 · Cited by 3,707
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,400
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Blaha, M. J., Dai, S., Ford, E. S., Fox, C. S., Franco, S., et al. (2014) · Circulation · doi:10.1161/01.cir.0000442015.53336.12 · Cited by 1,408
Tang, W. H. W., Wang, Z., Kennedy, D. J., Wu, Y., Buffa, J. A., Agatisa-Boyle, B., Li, X. S., Levison, B. S., & Hazen, S. L. (2015) · Circulation Research · doi:10.1161/circresaha.116.305360 · Cited by 1,223
Bennett, B. J., Vallim, T. Q. D. A., Wang, Z., Shih, D. M., Meng, Y., Gregory, J., Allayee, H., Lee, R., Graham, M., Crooke, R., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.011 · Cited by 1,070
Mueller, S., Saunier, K., Hanisch, C., Norin, E., Alm, L., Midtvedt, T., Cresci, A., Silvi, S., Orpianesi, C., Verdenelli, M. C., et al. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.72.2.1027-1033.2006 · Cited by 1,006
Wang, Z., Tang, W. H. W., Buffa, J. A., Fu, X., Britt, E. B., Koeth, R. A., Levison, B. S., Fan, Y., Wu, Y., & Hazen, S. L. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu002 · Cited by 559
Trends in meat consumption in the USA
Daniel, C. R., Cross, A. J., Koebnick, C., & Sinha, R. (2011) · Public Health Nutrition · doi:10.1017/s1368980010002077 · Cited by 504
Trøseid, M., Ueland, T., Hov, J. R., Svardal, A., Gregersen, I., Dahl, C. P., Aakhus, S., Gude, E., Bjørndal, B., Halvorsen, B., et al. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12328 · Cited by 464
Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden
Stubbs, J. R., House, J. A., Ocque, A. J., Zhang, S., Johnson, C., Kimber, C., Schmidt, K., Gupta, A., Wetmore, J. B., Nolin, T. D., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014111063 · Cited by 450
Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet
Gao, X., Liu, X., Xu, J., Xue, C., Xue, Y., & Wang, Y. (2014) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2014.03.001 · Cited by 360
A Combined Epidemiologic and Metabolomic Approach Improves CKD Prediction
Rhee, E. P., Clish, C. B., Ghorbani, A., Larson, M. G., Elmariah, S., McCabe, E., Yang, Q., Cheng, S., Pierce, K., Deik, A., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012101006 · Cited by 307
Bae, S., Ulrich, C. M., Neuhouser, M. L., Malysheva, O., Bailey, L. B., Xiao, L., Brown, E. C., Cushing-Haugen, K. L., Zheng, Y., Cheng, T.-Y. D., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1835 · Cited by 253
Lever, M., George, P. M., Slow, S., Bellamy, D., Young, J. M., Ho, M., McEntyre, C. J., Elmslie, J. L., Atkinson, W., Molyneux, S. L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114969 · Cited by 223
Fish Consumption, Fish Oil, Lipids, and Coronary Heart Disease
Stone, N. J. (1996) · Circulation · doi:10.1161/01.cir.94.9.2337 · Cited by 203
Gut microbiota metabolism of l-carnitine and cardiovascular risk
Ussher, J. R., Lopaschuk, G. D., & Arduini, A. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.10.013 · Cited by 172
Mente, A., Chalcraft, K., Ak, H., Davis, A. D., Lonn, E., Miller, R., Potter, M. A., Yusuf, S., Anand, S. S., & McQueen, M. J. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.06.016 · Cited by 128
Comparison of the gut microbiota of people in France and Saudi Arabia
Yasir, M., Angelakis, E., Bibi, F., Azhar, E. I., Bachar, D., Lagier, J., Gaborit, B., Hassan, A. M., Jiman-Fatani, A. A., Alshali, K. Z., et al. (2015) · Nutrition and Diabetes · doi:10.1038/nutd.2015.3 · Cited by 118
Yang, B., Lin, H., Xu, C., Liu, Y., Wang, H., Han, H. J., & Wang, Z. (2005) · Cellular Physiology and Biochemistry · doi:10.1159/000089842 · Cited by 114
Processing of meats and cardiovascular risk: time to focus on preservatives
Micha, R., Michas, G., Lajous, M., & Mozaffarian, D. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-136 · Cited by 93
Xiong, Y., Zhao, Y., Goruk, S. D., Oilund, K., Field, C. J., Jacobs, R. L., & Curtis, J. M. (2012) · Journal of Chromatography B · doi:10.1016/j.jchromb.2012.10.038 · Cited by 89
McEntyre, C. J., Lever, M., Chambers, S. T., George, P. M., Slow, S., Elmslie, J. L., Florkowski, C. M., Lunt, H., & Krebs, J. D. (2014) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563214545346 · Cited by 70
Urinary excretion of methylamines in men with varying intake of fish from the baltic sea
Svensson, B. ‐., Åkesson, B., Nilsson, A., & Paulsson, K. (1994) · Journal of Toxicology and Environmental Health · doi:10.1080/15287399409531853 · Cited by 66
Raymond, J. A. (1994) · Fish Physiology and Biochemistry · doi:10.1007/bf00004115 · Cited by 60
Danne, O., Lueders, C., Storm, C., Frei, U. A., & Möckel, M. M. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.05.001 · Cited by 57
Danne, O., & Möckel, M. M. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.2 · Cited by 48
Atmospheric pressure ion mobility spectrometry of protonated and sodiated peptides
Wu, C., Klasmeier, J., & Hill, H. H. (1999) · Rapid Communications in Mass Spectrometry · doi:10.1002/(sici)1097-0231(19990630)13:12 · Cited by 43
Haissman, J. M., Knudsen, A., Hoel, H., Kjær, A., Kristoffersen, U. S., Berge, R. K., Katzenstein, T. L., Svardal, A. M., Ueland, T., Aukrust, P., et al. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000843 · Cited by 43
Saely, C. H., Vonbank, A., Rein, P., Woess, M., Beer, S., Aczél, S., Jankovic, V., Boehnel, C., Risch, L., & Drexel, H. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.07.024 · Cited by 36
Self-citationEisert, R., Oftedal, O., Lever, M., Ramdohr, S., Breier, B. H., & Barrell, G. K. (2005) · Marine Ecology Progress Series · doi:10.3354/meps300213 · Cited by 35
Choline for diagnosis and prognostication of acute coronary syndromes in the Emergency Department
Body, R. M., Griffith, C., Keevil, B. G., McDowell, G., Carley, S. D., Ferguson, J., & Mackway-Jones, K. C. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.03.049 · Cited by 25
Crichton, G. E., Elias, M. F., Davey, A., Sauvageot, N., Delagardelle, C., Beissel, J., & Alkerwi, A. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-253 · Cited by 24
Wang, Z., & Jones, A. D. (2014) · Analytical Chemistry · doi:10.1021/ac502205y · Cited by 21
Buchman, A. L., Jenden, D. J., Suki, W. N., & Roch, M. (2000) · Journal of Renal Nutrition · doi:10.1053/jren.2000.7411 · Cited by 18
İlçöl, Y. Ö., Dönmez, O., Yavuz, M., Dilek, K., Yurtkuran, M., & Ulus, İ. H. (2002) · Clinical Biochemistry · doi:10.1016/s0009-9120(02)00319-3 · Cited by 15
Metabolites in the developing rat liver — A proton nuclear magnetic resonance spectroscopic study
RAFTER, J. E. M., Bates, T. E., Bell, J. D., & Iles, R. A. (1991) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(91)90162-a · Cited by 13
Tang, W. H. W., Wang, Z., Wu, Y., Fan, Y., Koeth, R., & Hazen, S. L. (2013) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(13)60750-0 · Cited by 8
Research works printed but not linked: 1
- Kidney disease, 2012, Improving global outcomes (kdigo) acute kidney injury work group. Kdigo clinical practice guideline for acute kidney injury, Kidney Inter., 2, 1
Cited by
Sorted by citations
Janeiro, M., Ramírez, M., Milagro, F., Martínez, J., & Solas, M. (2018) · Nutrients · doi:10.3390/nu10101398 · Cited by 631
“, (2015) [47] did an 8 years follow-up study trying to relate plasma TMAO, betaine or choline levels with cardiovascular disease (CVD), but the results showed that the levels were confounded by impaired kidney function or poor metabolic control and they were not associated with presence, incidence or events of coronar…”
BackgroundSchiattarella, G. G., Sannino, A., Toscano, E., Giugliano, G., Gargiulo, G., Franzone, A., Trimarco, B., Esposito, G., & Perrino, C. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx342 · Cited by 563
Heianza, Y., Ma, W., Manson, J. E., Rexrode, K. M., & Qi, L. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004947 · Cited by 544
Trimethylamine N-oxide: the good, the bad and the unknown.
Velasquez, M., Ramezani, A., Manal, A., & Raj, D. (2016) · Toxins · doi:10.3390/toxins8110326 · Cited by 504
Li, X. S., Obeid, S., Klingenberg, R., Gencer, B., Mach, F., Räber, L., Windecker, S., Rodondi, N., Nanchen, D., Muller, O., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehw582 · Cited by 479
Metadata
- Authors
- Mueller, D. M., Allenspach, M., Othman, A., Saely, C. H., Muendlein, A., Vonbank, A., Drexel, H., & von Eckardstein, A.
- Affiliations
- University of Zurich (CH)
- Landeskrankenhaus Feldkirch (AT)
- ORCID
- Venue
- Atherosclerosis
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 243
- Issue
- 2
- Pages
- 638-644
- ISSN
- 0021-9150 (ISSN-L)
- OpenAlex
- W1751395982
- Cited by
- 217
- References
- 46
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 18 · 2023: 21 · 2022: 30 · 2021: 19 · 2020: 36 · 2019: 18 · 2018: 20 · 2017: 20 · 2016: 18 · 2015: 1
- FWCI
- 8.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Atherosclerosis (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Keywords
- trimethylamine N-oxide, betaine, choline, plasma biomarkers, renal function, renal dysfunction, metabolic control, diabetes mellitus, metabolic syndrome, coronary artery disease, myocardial infarction, cardiovascular risk, gut microbiota
- MeSH terms
- Aged, Betaine, Blood Glucose, Choline, Chromatography, Liquid, Coronary Disease, Diabetes Mellitus, Female, Glomerular Filtration Rate, Humans, Kidney, Male, Methylamines, Middle Aged, Predictive Value of Tests, Prognosis, Time Factors, Reproducibility of Results, Biomarkers, Coronary Angiography, Spectrometry, Mass, Electrospray Ionization, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
